The lipoprotein abnormality in Tangier disease: quantitation of A apoproteins
about
A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian familyCharacterization of apolipoprotein A-I- and A-II-containing lipoproteins in a new case of high density lipoprotein deficiency resembling Tangier disease and their effects on intracellular cholesterol efflux.Demonstration of human apolipoprotien A in isolated mucosal cells from small intestine and isolated hepatocytes.Postprandial hypertriglyceridaemia in patients with Tangier disease.Plasma apolipoproteins and lipids in normal persons and patients with hypertensionEmerging roles of the intestine in control of cholesterol metabolism.A-Imilano apoprotein. Isolation and characterization of a cysteine-containing variant of the A-I apoprotein from human high density lipoproteinsIsolation and characterization of an abnormal high density lipoprotein in Tangier DiesaseCharacterization of high density lipoproteins in patients heterozygous for Tangier disease.Defective regulation of phosphatidylcholine-specific phospholipases C and D in a kindred with Tangier disease. Evidence for the involvement of phosphatidylcholine breakdown in HDL-mediated cholesterol efflux mechanisms.Tangier disease: a disorder of intracellular membrane traffic.ABC transporters, atherosclerosis and inflammation.Tangier disease: defective recombination of a specific Tangier apolipoprotein A-I isoform (pro-apo A-i) with high density lipoproteins.Quantitation of the two major apoproteins of human high density lipoproteins by solid phase radioimmunoassay.Charge-shift electrophoresis of apolipoproteins from normal humans and patients with Tangier disease.Vigna unguiculata modulates cholesterol induced cardiac markers, genotoxicity and gene expressions profile in an experimental rabbit model.
P2860
Q24597463-4037E018-6EC5-43A1-9421-7225AA4AC20AQ33890253-BAD32016-1944-4DFA-B52A-5784DF140DEAQ34475148-06951134-B730-475E-A02F-B86B6FA837D2Q35587205-2591F738-927A-4647-91B4-40FD2063CAFDQ35954157-77B0E373-DA52-4D6C-AC95-60A6CA85C3B8Q36638194-750DD520-F5D9-4A0D-AD98-71261990EF8EQ37024338-347732D1-A3BC-45E6-A7E2-64A7D2099E86Q37045690-D1234AE9-2D1E-4FD9-A03F-AA0369AC4C85Q37048066-49F62DB5-6152-427E-A9F8-7D80CBBA50B3Q37361499-5CC77319-2DDF-4905-AE81-9DAC23DBFB77Q37543091-170B56A8-DB73-4F09-A4D0-D1A90BBC5940Q37688500-2843FF44-C11F-42AE-A0FA-0F2B4155B870Q37690473-4E4486E2-385D-40CC-BDC8-598F3694F825Q40158965-337625DF-FC76-4F7B-B80C-C64B89DEF15BQ40203745-0CA34852-EA10-4AEF-A870-1A5CC042238DQ54261181-E30DD9B1-F98D-4431-AEC1-084B809F5398
P2860
The lipoprotein abnormality in Tangier disease: quantitation of A apoproteins
description
1977 nî lūn-bûn
@nan
1977年の論文
@ja
1977年論文
@yue
1977年論文
@zh-hant
1977年論文
@zh-hk
1977年論文
@zh-mo
1977年論文
@zh-tw
1977年论文
@wuu
1977年论文
@zh
1977年论文
@zh-cn
name
The lipoprotein abnormality in Tangier disease: quantitation of A apoproteins
@ast
The lipoprotein abnormality in Tangier disease: quantitation of A apoproteins
@en
type
label
The lipoprotein abnormality in Tangier disease: quantitation of A apoproteins
@ast
The lipoprotein abnormality in Tangier disease: quantitation of A apoproteins
@en
prefLabel
The lipoprotein abnormality in Tangier disease: quantitation of A apoproteins
@ast
The lipoprotein abnormality in Tangier disease: quantitation of A apoproteins
@en
P2093
P2860
P356
P1476
The lipoprotein abnormality in Tangier disease: quantitation of A apoproteins
@en
P2093
P2860
P304
P356
10.1172/JCI108672
P407
P577
1977-03-01T00:00:00Z